Middle East and Africa Molecular Biology Enzymes, Kits, and Reagents Market Forecast by 2028

The molecular biology enzymes, kits, and reagents market in MEA is expected to grow from US$ 537.68 million in 2021 to US$ 1,566.09 million by 2028; it is estimated to grow at a CAGR of 16.5% from 2021 to 2028.

Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in a deep economic recession due to the US sanctions. Also, the major source of economic stabilization in the Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage are major impacts observed in the region.The Saudi government policies favor domestic pharmaceutical manufacturers, including no import duties on raw materials & intermediate products and interest-free funding, thus supporting the growth of the pharmaceutical market in this region.

Similarly, the increasing incidence of COVID-19 is creating a massive demand for kits and reagents used to detect the COVID-19 virus. In April 2020, BGI Group, a Chinese genomics company, and Group-42, a UAE technology company, unveiled a new massive-throughput laboratory in the UAE to help with testing and diagnosis of the novel coronavirus. According to BGI, the lab will use RT-PCR diagnostic kits that have been approved by medical regulatory authorities in China, Europe, the US, and Japan. As molecular biology enzymes, kits, and reagents are majorly used in the detection of a novel coronavirus, so there was a high impact of COVID-19 on the molecular biology enzymes, kits & reagents market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA molecular biology enzymes, kits, and reagents market. The MEA molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.

MEA Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

MEA Molecular Biology Enzymes, Kits, and Reagents Market – By Product

• Enzymes

  • Polymerases
  • Ligases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Restriction Endonuclease
  • Other
• Kits and Reagents

MEA Molecular Biology Enzymes, Kits, and Reagents Market – By Application

• Epigenetics
• Sequencing
• Synthetic Biology
• Polymerase Chain Reaction
• Other

MEA Molecular Biology Enzymes, Kits, and Reagents Market – By End User

• Biotechnological and Pharmaceutical Companies
• Hospitals and Diagnostic Centres
• Academic and Research Institutes

MEA Molecular Biology Enzymes, Kits, and Reagents Market, by Country

• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

MEA Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned

• Agilent Technologies, Inc.
• F. HOFFMANN-LA ROCHE LTD
• Illumina, Inc.
• Merck KGAA
• MERIDIAN BIOSCIENCE, INC
• Promega Corporation
• Qiagen
• THERMO FISHER SCIENTIFIC INC

Middle East and Africa Molecular Biology Enzymes, Kits, and Reagents Report Scope